FCF YoY
+49.23%
OCF YoY
+7.63%
Capex YoY
-28.07%
FCF Conversion Δ
+17.9 pp
Free cash flow bridge for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $151.10M
FCF bridge breakdown for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $306.90M | — |
| Operating Cash Flow | $50.70M | +33.6% |
| Capital Expenditure | $100.40M | +66.4% |
| Free Cash Flow | $458.00M | — |
- Prior Free Cash Flow$306.90M
- Operating Cash Flow$50.70M
- Capital Expenditure$100.40M
- Free Cash Flow$458.00M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement